MAPT and early-onset autosomal dominant Alzheimer disease: We recommend future longitudinal studies incorporating biomarkers like amyloid, total tau, and phosphorylated tau (P-tau) to determine if olive leaf extract (OLE) can alter the progression of Alzheimer’s disease (AD) pathology.